18F-mFBG PET Detects Neuroblastoma Recurrence Prior to 123I-mIBG SPECT
- 5 November 2026
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Pediatric Hematology/Oncology
Abstract
Background: A high-risk stage M neuroblastoma patient suspected of residual disease in a T3-4 paraspinal soft tissue mass had no evidence of disease on MRI or 123 I- m IBG SPECT/CT. Observations: 18 F- m FBG PET/CT performed in a clinical trial showed abnormalities in the upper and lower thoracic spine, lumbar spine, and pelvis. Two months later, the MRI was unchanged, and 123 I- m IBG SPECT/CT showed only an equivocal upper thoracic spine focus. 123 I- m IBG SPECT/CT and MRI at 4 months post- 18 F- m FBG showed positive findings in the thoracic spine consistent with neuroblastoma. Conclusions: Follow-up confirmed that 18 F- m FBG PET/CT identified neuroblastoma at least 2 months prior to 123 I- m IBG and MRI.Keywords
Funding Information
- Innervate Radiopharmaceuticals LLC
This publication has 17 references indexed in Scilit:
- Prominent 18F-MFBG Uptake in Brown Adipose Tissue in a Pediatric Patient With PheochromocytomaClinical Nuclear Medicine, 2026
- False Positive Findings on 18F-MFBG PET/CT Attributable to Benign Neural Differentiation in a Pediatric Patient With NeuroblastomaClinical Nuclear Medicine, 2026
- False Uptake of 18F-MFBG and 68Ga-DOTATATE in the Stellate Ganglion in a Pediatric Patient With NeuroblastomaClinical Nuclear Medicine, 2026
- Early Detection of Neuroblastoma Recurrence on 18F mFBG PETClinical Nuclear Medicine, 2026
- [18F]MFBG PET/CT outperforming [123I]MIBG SPECT/CT in the evaluation of neuroblastomaEuropean Journal of Nuclear Medicine and Molecular Imaging, 2023
- [18F]mFBG PET-CT for detection and localisation of neuroblastoma: a prospective pilot studyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2022
- [18F] MFBG PET imaging: biodistribution, pharmacokinetics, and comparison with [123I] MIBG in neural crest tumour patientsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2022
- Asymmetric Thoracic Metaiodobenzylguanidine (MIBG) Activity Due to Prior Radiation TherapyClinical Nuclear Medicine, 2015
- Persistent Intense MIBG Activity in the Liver Caused by Prior RadiationClinical Nuclear Medicine, 2014
- Criteria for evaluation of disease extent by 123I-metaiodobenzylguanidine scans in neuroblastoma: a report for the International Neuroblastoma Risk Group (INRG) Task ForceBritish Journal of Cancer, 2010